CLINICAL_TRIALS
withdrawal
· 2021-02-24
Clinical Trial Update: Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension [Phase 3]
Summary
Phase 3 trial investigating Leningrado 5 Association for hypertension was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMS | Conditions: Arterial Hypertension | Phase 3 | Status: WITHDRAWN